Skip to main content
. 2021 Jun 23;11:647175. doi: 10.3389/fonc.2021.647175

Figure 4.

Figure 4

IRAK2 overexpression decreased OML1-R-generated in vivo tumor growth and enhanced radiosensitivity in the mice xenograft model. (A) In the mice xenograft model, IRAK2-overexpressed OML1-R-generated tumors had a relatively lower tumor growth rate than that of control OML1-R-generated tumors (P < 0.001). (B) Schema of cell injection and radiation treatments (upper panel). Since the 40th day after cancer cell injection, control and IRAK2-overexpressed mice were treated with RT per 4 days (i.e., a fraction size of 5 Gy by ten fractions to an accumulative dose of 50 Gy). The IRAK2-overexpressed mice had a smaller tumor volume than that of control mice at the time of radiotherapy (P = 0.0310; lower panel). (C) The expression of IRAK2, cleaved caspase-8, and cleaved caspase-3 in tumor tissues from control and IRAK2-overexpressed mice after radiotherapy were detected by immunohistochemical staining. (D) Immunoblotting analysis of the indicated proteins in lung tissues from control and IRAK2-overexpressed mice after irradiation. Densitometry-derived values (bottom) were normalized with the control set as 1. β-actin served as the loading control for normalization. Data were presented as mean ± SD. ‘***’ represented P < 0.001. All experiments were performed in triplicate.